Literature DB >> 8787682

Long-lasting memory T cell responses following self-limited acute hepatitis B.

A Penna1, M Artini, A Cavalli, M Levrero, A Bertoletti, M Pilli, F V Chisari, B Rehermann, G Del Prete, F Fiaccadori, C Ferrari.   

Abstract

The molecular and cellular basis of long-term T cell memory against viral antigens is still largely undefined. To characterize anti-viral protection by memory T cells against non-cytopathic viruses able to cause acute self-limited and chronic infections, such as the hepatitis B virus (HBV), we studied HLA class II restricted responses against HBV structural antigens in 17 patients with acute hepatitis B, during the acute stage of infection and 2.2 to 13 yr after clinical resolution of disease. Results indicate that: (a) significant T cell proliferative responses to HBV nucleocapsid antigens were detectable in all patients during the acute phase of infection and in 14/17 also 2-13 yr after clinical resolution of disease; b) long-lasting T cell responses were sustained by CD45RO+T cells, predominantly expressing the phenotype of recently activated cells; c) limiting dilution analysis showed that in some patients the frequency of HBV-specific T cells was comparable to that observed in the acute stage of infection and, usually, higher than in patients with chronic HBV infection; d) the same amino acid sequences were recognized by T cells in the acute and recovery phases of infection; and e) HBV-DNA was detectable by nested-PCR in approximately half of the subjects. to conclusion, our results show that vigorous anti-viral T cell responses are detectable in vitro several years after clinical recovery from acute hepatitis B. Detection of minute amounts of virus in some recovered subjects suggests that long-term maintenance of an active anti-viral T cell response could be important not only for protection against reinfection but also for keeping the persisting virus under tight control.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787682      PMCID: PMC507541          DOI: 10.1172/JCI118902

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

Review 1.  The central role of follicular dendritic cells in lymphoid tissues.

Authors:  F Schriever; L M Nadler
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

Review 2.  Follicular dendritic cells as accessory cells.

Authors:  J G Tew; M H Kosco; G F Burton; A K Szakal
Journal:  Immunol Rev       Date:  1990-10       Impact factor: 12.988

Review 3.  The synergy between naive and memory T cells during activation.

Authors:  A N Akbar; M Salmon; G Janossy
Journal:  Immunol Today       Date:  1991-06

Review 4.  Memory B and T cells.

Authors:  E S Vitetta; M T Berton; C Burger; M Kepron; W T Lee; X M Yin
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

5.  Redevelopment of hepatitis B surface antigen after renal transplantation.

Authors:  P Marcellin; E Giostra; M Martinot-Peignoux; M A Loriot; M L Jaegle; P Wolf; C Degott; F Degos; J P Benhamou
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

6.  Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B.

Authors:  M C Jung; U Spengler; W Schraut; R Hoffmann; R Zachoval; J Eisenburg; D Eichenlaub; G Riethmüller; G Paumgartner; H W Ziegler-Heitbrock
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

7.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.

Authors:  G F Del Prete; M De Carli; C Mastromauro; R Biagiotti; D Macchia; P Falagiani; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Authors:  A Penna; F V Chisari; A Bertoletti; G Missale; P Fowler; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

9.  T cell memory is short-lived in the absence of antigen.

Authors:  D Gray; P Matzinger
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

10.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.

Authors:  S Oehen; H Waldner; T M Kündig; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  70 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 4.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 5.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 6.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

7.  Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.

Authors:  N Obeng-Adjei; D K Choo; J Saini; J Yan; P Pankhong; A Parikh; J S Chu; D B Weiner
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987

8.  Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Authors:  Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai V Naoumov
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

9.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.

Authors:  S Menne; J Maschke; M Lu; H Grosse-Wilde; M Roggendorf
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.